Cited by 181Reproductive Health and TechnologiesOvarian function and disordersAssisted Reproductive Technology and Twin Pregnancy

Weight reduction intervention for obese infertile women prior to IVF: A randomized controlled trial

Open access
Einarsson, Snorri, Bergh, Christina, Friberg, Britt, Pinborg, Anja, Klajnbard, Anna, Karlström, Per-Olof, Kluge, Linda, Larsson, Ingrid +5 more·2017·Human Reproduction

Abstract

STUDY QUESTION: Does an intensive weight reduction programme prior to IVF increase live birth rates for infertile obese women? SUMMARY ANSWER: An intensive weight reduction programme resulted in a large weight loss but did not substantially affect live birth rates in obese women scheduled for IVF. WHAT IS ALREADY KNOWN: Among obese women, fertility and obstetric outcomes are influenced negatively with increased risk of miscarriage and a higher risk of maternal and neonatal complications. A recent large randomized controlled trial found no effect of lifestyle intervention on live birth in infertile obese women. STUDY DESIGN, SIZE, DURATION: A prospective, multicentre, randomized controlled trial was performed between 2010 and 2016 in the Nordic countries. In total, 962 women were assessed for eligibility and 317 women were randomized. Computerized randomization with concealed allocation was performed in the proportions 1:1 to one of two groups: weight reduction intervention followed by IVF-treatment or IVF-treatment only. One cycle per patient was included. PARTICIPANTS/MATERIALS, SETTING, METHODS: Nine infertility clinics in Sweden, Denmark and Iceland participated. Women under 38 years of age planning IVF, and having a BMI ≥30 and <35 kg/m2 were randomized to two groups: an intervention group (160 patients) with weight reduction before IVF, starting with 12 weeks of a low calorie liquid formula diet (LCD) of 880 kcal/day and thereafter weight stabilization for 2-5 weeks, or a control group (157 patients) with IVF only. MAIN RESULTS AND ROLE OF CHANCE: In the full analysis set (FAS), the live birth rate was 29.6% (45/152) in the weight reduction and IVF group and 27.5% (42/153) in the IVF only group. The difference was not statistically significant (difference 2.2%, 95% CI: 12.9 to -8.6, P = 0.77). The mean weight change was -9.44 (6.57) kg in the weight reduction and IVF group as compared to +1.19 (1.95) kg in the IVF only group, being highly significant (P < 0.0001). Significantly more live births were achieved through spontaneous pregnancies in the weight reduction and IVF group, 10.5% (16) as compared to the IVF only group 2.6% (4) (P = 0.009). Miscarriage rates and gonadotropin dose used for IVF stimulation did not differ between groups. Two subgroup analyses were performed. The first compared women with PCOS in the two randomized groups, and the second compared women in the weight reduction group reaching BMI ≤ 25 kg/m2 or reaching a weight loss of at least five BMI units to the IVF only group. No statistical differences in live birth rates between the groups in either subgroup analysis were found. LIMITATIONS, REASON FOR CAUTION: The study was not powered to detect a small increase in live births due to weight reduction and was not blinded for the patients or physician. Further, the intervention group had a longer time to achieve a spontaneous pregnancy, but were therefore slightly older than the control group at IVF. The study only included women with a BMI lower than 35 kg/m2. WIDER IMPLICATIONS OF THE FINDINGS: The study suggests that weight loss for obese women (BMI: 30-34.9 kg/m2) may not rectify the outcome in IVF cycles, although a significant higher number of spontaneous conceptions occurred in the weight loss group. Also, the study suggests that intensive weight reduction with LCD treatment does not negatively affects the results. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by Sahlgrenska University Hospital (ALFGBG-70 940), Merck AB, Solna, Sweden (an affiliate of Merck KGaA, Darmstadt, Germany), Impolin AB, Hjalmar Svensson Foundation and Jane and Dan Olsson Foundation. Dr Thurin-Kjellberg reports grants from Merck, non-financial support from Impolin AB, during the conduct of the study, and personal fees from Merck outside the submitted work. Dr Friberg reports personal fees from Ferring, Merck, MSD, Finox and personal fees from Studentlitteratur, outside the submitted work. Dr Englund reports personal fees from Ferring, and non-financial support from Merck, outside the submitted work. Dr Bergh reports and has been reimbursed for: writing a newsletter twice a year (Ferring), lectures (Ferring, MSD, Merck), and Nordic working group meetings (Finox). Dr Karlström reports lectures (Ferring, Finox, Merck, MSD) and Nordic working group meetings (Ferring). Ms Kluge, Dr Einarsson, Dr Pinborg, Dr Klajnbard, Dr Stenlöf, Dr Larsson, Dr Loft and Dr Wistrand have nothing to disclose. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov number, NCT01566929. TRIAL REGISTRATION DATE: 23-03-2012. DATE OF FIRST PATIENT'S ENROLMENT: 05-10-2010.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dex235

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In overweight women undergoing assisted reproduction technologies, weight loss does not significantly differ in pregnancy rates compared to control.

    “However, in the group of overweight women who underwent assisted reproduction technologies (ARTs), such as in vitro fertilization (IVF), there was no significant difference in pregnancy rates between women who achieved weight loss and the control group [70].”
  • In overweight women, weight loss before insemination increases spontaneous pregnancy rate compared to no weight loss.

    “According to a study by Einarsson et al., overweight women who lost weight before insemination had an increased spontaneous pregnancy rate compared to overweight women who did not lose weight.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Einarsson, S., Bergh, C., Friberg, B., Pinborg, A., Klajnbard, A., Karlström, P.-O., Kluge, L., Larsson, I., Loft, A., Mikkelsen-Englund, A.-L., Stenlöf, K., Wistrand, A., & Thurin-Kjellberg, A.
Affiliations
  • University of Gothenburg (SE)
  • Sahlgrenska University Hospital (SE)
  • Skåne University Hospital (SE)
  • Hvidovre Hospital (DK)
  • Herlev Hospital (DK)
  • Karolinska University Hospital (SE)
  • Copenhagen University Hospital (DK)
  • Örebro University Hospital (SE)
Venue
Human Reproduction
Published
2017-06-29
Volume
32
Issue
8
Pages
1621-1630
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2729389999
Cited by
181
References
34
Citations by year
2026: 9 · 2025: 21 · 2024: 20 · 2023: 28 · 2022: 36 · 2021: 26 · 2020: 20 · 2019: 11 · 2018: 7 · 2017: 2 · 2015: 1
FWCI
12.71
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Merck KGaA
  • Gentofte Hospital
  • Herlev Hospital
  • Örebro Universitet
  • Stiftelsen Handlanden Hjalmar Svenssons
  • Rigshospitalet
  • Sahlgrenska Universitetssjukhuset (70940, ALFGBG-70940)
  • Universitetssjukhuset Örebro
  • Hvidovre Hospital
  • Skånes universitetssjukhus
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
Keywords
obesity, weight loss, in vitro fertilization, infertility, live birth rate, spontaneous conception, assisted reproduction outcomes, lifestyle intervention, body mass index, miscarriage
MeSH terms
Adult, Birth Rate, Female, Fertilization in Vitro, Humans, Infertility, Female, Obesity, Ovulation Induction, Pregnancy, Pregnancy Outcome, Prospective Studies, Weight Loss, Treatment Outcome, Live Birth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review